Home > PS Ratio > PANACEA BIOTEC

PANACEA BIOTEC
PS (Price/Sales) Ratio

The Current P/S Ratio of PANACEA BIOTEC is 1.55.

Share Price ₹139.8May 03,2024
Market Cap ₹857.0 Cr
Sales-TTM₹551.6 CrTTM-Consolidated Results
Price/Sales1.55xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for PANACEA BIOTEC
Please provide your vote to see the results
PANACEA BIOTEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of PANACEA BIOTEC

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of PANACEA BIOTEC is calculated as :

Current Market Cap [ ₹857.0 Cr] as on May 03,2024

(/) Sales [ ₹551.6 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.55x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for PANACEA BIOTEC , the investors are currently willing to pay '1.55 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of PANACEA BIOTEC !

The chart below summarizes the trend in P/S Ratio of PANACEA BIOTEC over the last five years.

Historical PS (Price/Sales) ratio chart of PANACEA BIOTEC


PS Ratio Performance Analysis for PANACEA BIOTEC

- PANACEA BIOTEC 's latest p/e ratio is 1.55x.

- PANACEA BIOTEC 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.69x.

- PANACEA BIOTEC 's operated at median p/e ratio of 1.44x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, PANACEA BIOTEC 's p/e ratio peaked in Mar2019 at 2.66x.

- PANACEA BIOTEC 's p/e ratio hit its five-year low in Mar2020 of 1.23x.


How does PANACEA BIOTEC 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
PANACEA BIOTEC 551.61.55857.0
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.63361,916.0
CIPLA LTD25,350.24.54115,034.0
DR REDDYS LABORATORIES LTD27,212.53.89105,929.0
ZYDUS LIFESCIENCES LTD19,024.25.27100,322.0
DIVIS LABORATORIES LTD7,492.814.00104,873.0
MANKIND PHARMA LTD9,946.39.3292,708.2
TORRENT PHARMACEUTICALS LTD10,474.08.8392,483.6
LUPIN LTD19,480.13.8775,438.0
AUROBINDO PHARMA LTD27,894.72.4267,541.1
ABBOTT INDIA LTD5,753.49.6655,555.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PANACEA BIOTEC 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.55x
Max industry PS 14.00x
Median industry PS 5.27x
Average industry PS 6.45x



You may also like the below Video Courses